Squarepoint’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
+32,744
| New | +$2.14M | ﹤0.01% | 1145 |
|
|
2021
Q4 | – | Sell |
-14,882
| Closed | -$488K | – | 2517 |
|
|
2021
Q3 | $488K | Sell |
14,882
-5,850
| -28% | -$192K | ﹤0.01% | 1399 |
|
|
2021
Q2 | $727K | Buy |
20,732
+7,580
| +58% | +$266K | ﹤0.01% | 1377 |
|
|
2021
Q1 | $475K | Buy |
+13,152
| New | +$475K | ﹤0.01% | 1570 |
|
|
2020
Q3 | – | Sell |
-6,842
| Closed | -$221K | – | 2309 |
|
|
2020
Q2 | $221K | Buy |
+6,842
| New | +$221K | ﹤0.01% | 1714 |
|
|
2020
Q1 | – | Sell |
-15,810
| Closed | -$975K | – | 1826 |
|
|
2019
Q4 | $975K | Buy |
+15,810
| New | +$975K | 0.01% | 1320 |
|
|
2019
Q3 | – | Sell |
-17,372
| Closed | -$1.43M | – | 2214 |
|
|
2019
Q2 | $1.43M | Buy |
17,372
+8,830
| +103% | +$726K | 0.01% | 1025 |
|
|
2019
Q1 | $603K | Sell |
8,542
-6,030
| -41% | -$426K | 0.01% | 1370 |
|
|
2018
Q4 | $656K | Buy |
+14,572
| New | +$656K | 0.01% | 1092 |
|
|
2018
Q2 | – | Sell |
-3,796
| Closed | -$221K | – | 1731 |
|
|
2018
Q1 | $221K | Sell |
3,796
-16,954
| -82% | -$987K | ﹤0.01% | 1447 |
|
|
2017
Q4 | $1.34M | Buy |
+20,750
| New | +$1.34M | 0.02% | 693 |
|
|
2017
Q3 | – | Sell |
-6,097
| Closed | -$285K | – | 1583 |
|
|
2017
Q2 | $285K | Buy |
+6,097
| New | +$285K | 0.01% | 1144 |
|
|
2017
Q1 | – | Sell |
-4,088
| Closed | -$248K | – | 1499 |
|
|
2016
Q4 | $248K | Buy |
4,088
+184
| +5% | +$11.2K | 0.01% | 1271 |
|
|
2016
Q3 | $259K | Buy |
+3,904
| New | +$259K | 0.02% | 791 |
|
|
2016
Q2 | – | Sell |
-18,645
| Closed | -$628K | – | 1087 |
|
|
2016
Q1 | $628K | Buy |
18,645
+7,700
| +70% | +$259K | 0.05% | 532 |
|
|
2015
Q4 | $494K | Buy |
+10,945
| New | +$494K | 0.05% | 541 |
|